| Description | E2F1 Human Pre-designed siRNA Set A contains three designed siRNAs for E2F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components E2F1 siRNA-1: 5 nmol (HPLC) E2F1 siRNA-2: 5 nmol (HPLC) E2F1 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 E2F1 Human Pre-designed siRNA Set A contains three designed siRNAs for E2F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components E2F1 siRNA-1: 5 nmol (HPLC) E2F1 siRNA-2: 5 nmol (HPLC) E2F1 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Lipoprotein Lipase Activator is a cell-permeable benzylphosphonate derivative that selectively induces lipoprotein lipase (LPL) mRNA and protein levels, but does not exhibit PPARα or PPARγ agonistic activities. Lipoprotein Lipase Activator lowers serum lipid levels and plasma triglyceridesLipoprotein Lipase Activator is a cell-permeable benzylphosphonate derivative that selectively induces lipoprotein lipase (LPL) mRNA and protein levels, but does not exhibit PPARα or PPARγ agonistic activities. Lipoprotein Lipase Activator lowers serum lipid levels and plasma triglycerides with concomitant elevation in high-density lipoprotein cholesterol (HDL-C) in animal models. Lipoprotein Lipase Activator also induces fatty acid oxidation related enzymes, lowers free fatty acids (FFA), and minimizes fat accumulation. Also reported to suppress the plasma levels of TNF-a and COX-2 and displays anti-tumor properties... Read More | Biochemical Test:SDS-PAGE (purity > 80%); Western blot with patient sample.Calculated Isoelectric Point:pH 6.64 | Purity:>90%, by SDS-PAGE visualized with Coomassie® Blue Staining.This protein is one of the nuclear-coded polypeptide chains of cytochrome c oxidase, the terminal oxidase in mitochondrial electron transport | Format:1-ComponentEnzyme:Horseradish peroxidase |